Akari Therapeutics Plc 10-Q filing
Filed 2025-08-13 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001641172-25-023569
- Form type
- 10-Q
- CIK
- 0001541157
- Primary document
- https://www.sec.gov/Archives/edgar/data/1541157/000164117225023569/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akari Therapeutics Plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-6.6M | - | - |
| Net Income | $-5.6M | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $2.7M | - | - |
| Total Assets | $50.9M | - | - |
| Total Liabilities | $25.3M | - | - |
| Shareholders Equity | $25.6M | - | - |
| Operating Cash Flow | $-5.4M | - | - |